Share Name Share Symbol Market Type Share ISIN Share Description
Microsaic LSE:MSYS London Ordinary Share GB00B547ZY09 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 2.90p 2.80p 3.00p 2.90p 2.90p 2.90p 0 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 0.9 -3.4 -2.9 - 5.26

Microsaic Share Discussion Threads

Showing 1301 to 1325 of 1325 messages
Chat Pages: 53  52  51  50  49  48  47  46  45  44  43  42  Older
DateSubjectAuthorDiscuss
23/1/2018
08:12
Disclosure of Microsaic's global biopharma partner on successful technology trials and subsequent productisation and commercialisation will be a game changer for all invested, in the meantime plenty of upside very likely as other good news rolls in. Gla ;-)
moneymunch
23/1/2018
08:12
Market cap under £6m, up to £4m cash in the bank and on going cash revenue stream from the sale of product and consumables to existing customers and OEM'S, and revenues are expected to be much improved H2 2017, and so a positive trading statement possible at anytime...Peter Grant ex CEO of Skypharma who was at the helm during their meteoric rise and subsequent £440m merger, and of course an ongoing technology collaboration with a global biopharma partner with Microsaic's technology being integrated into their products and equipment and already validated by their partner's BIG pharma end users....a multi-bag in the making. Gla :-)
moneymunch
22/1/2018
18:48
Got to start somewhere! Glad to be on board.
bagpuss67
22/1/2018
15:52
They will do soon. Gla ;-)
moneymunch
22/1/2018
15:42
No one wants to buy more than 2k.....says it all lol
bobmonkeyhouse
22/1/2018
11:16
Well for the first time in a week I can actually sell some of these !!!!!!!!! Havent but would accept a £2k order
billthebank
20/1/2018
11:36
28/9/17 OUTLOOK The Board sees significant opportunities for its MS instruments being integrated into multiple areas of bioprocessing, and for diagnostics in the longer term. The Company is transforming the way it operates. It has a vision to help solve some of the major problems in human health. To do this, the Company aims to work with global partners with similar aspirations, which are prepared to co-fund R&D development costs and ensure that new product opportunities are adequately validated so they meet customer needs. The Company expects its full year 2017 revenue to be significantly lower than 2016. The shortfall in revenue is expected to be off-set by lower overheads as a result of cost reduction plans implemented in H1 2017 and that the full year loss before tax will be broadly in line with 2016. Progress has been made in addressing the difficult trading conditions and H2 2017 revenues are anticipated to be above H1 2017 based on current Q3 performance. htTps://uk.advfn.com/stock-market/london/microsaic-MSYS/share-news/Microsaic-Systems-plc-Interim-Results/75741969
moneymunch
20/1/2018
10:34
HOw does a falling share price look good? Have you sold when ramping again?
bobmonkeyhouse
19/1/2018
12:42
The current extension to the collaboration with their global biopharma is expected to lead to productisation and commercialisation of their technology and therefore will be reflected in their subsequent revenues...the NDA is in place until this time. Gl.;-) Disclosure of Microsaic's global biopharma partner with their global reach, which is expected in the coming weeks and months, will see the share price many multiples of the current price on successful trials and commercialisation imho......in the meantime with so few shares in circulation and most held tightly...a positive trading statement which is now expected will very likely see a significant jump in share price imho..Gl ;-) 13th December 2017 Q&A with Glenn Tracey Chief Executive Officer at Microsaic Systems PLC (LON:MSYS) Microsaic Systems plc Q&A with Glenn Tracey Chief Executive Officer at Microsaic Systems PLC (LON:MSYS) Microsaic Systems PLC (LON:MSYS) Chief Executive Officer Glenn Tracey caught up with Directors Talk for an exclusive interview to discuss the research agreement with a global biopharma partner, the meaning of a biopharmaceutical, the biologics market and why they are seeing the need for in-process mass spectrometry for biologics that perhaps they wouldn’t see for traditional drugs. Q1: Microsaic recently announced the signing of a research agreement with a global partner in biopharma, can you tell us a little bit more about that? A1: Yes, absolutely so I’ve got to say that we are under strict NDA in this particular case but what I can do is give you some context. Earlier in the year we successfully completed a significant joint feasibility phase to show dedicated at-line mass spec can assess the quality of biologics during the manufacture. I think perhaps the most important aspect of that phase was that we had substantial end-user validation from big pharma and just to say that these are end-users whom our partner has very good global reach. What this new phase is it will bring more end-user validation to the approach, but I think the exciting deliverable is that we’ll be able to provide a lot more technical integration with the partner’s product. So, should this activity be successful, it will take us into the second half of 2018 and then that will proceed a period of productisation. As I said, I can’t give any details yet about the size and timeline for commercialisation, but the opportunity is significant to us, to Microsaic, and delivery is proportionate, I would say, to our timescales. hTtps://www.directors talk/microsaic-systems-plc-qa-ceo-glenn-tracey-lonmsys-2/412742383
moneymunch
19/1/2018
12:37
What happens if they don't disclose their global biopharma partner and are bound to secrecy?
2prsimo
19/1/2018
12:34
Lol you lowlife scumbag, looks good as far as I'm concerned...this will rise big time on positive news and will multi-bag on disclosure of their global biopharma partner....Gla holders....Microsaic's are currently looking to recruit a whole new team of scientists and engineers, presumably in anticipation of increased production and commercialisation of their technology, which is already being integrated into their partner's products and equipment and is already validated by their partner's BIG pharma end users....On and Up!!!;-)
moneymunch
19/1/2018
12:25
not looking good is it moneymunch. everyone knows your game now. disgusting reputation
bobmonkeyhouse
19/1/2018
11:40
Stephen, What's a few thousand shares difference gonna make!!!?? lol! Ok, you must be in the same boat as me....being greedy! Anyway, let's see where we go with this. Good luck.
k1ngkonggb
19/1/2018
11:34
Ps every chance this will close blue imho....the majority of shares are held tightly and maybe only 40m in free float from 181m... and the mm's have just managed to pick up a few on the cheap. Gla holders On and Up!!!;-)
moneymunch
19/1/2018
11:29
Lol Stephen, you really are pathetic mate.....watch and weep on the forthcoming value of my 2.2m plus Msys shares....Ker-Ching!!! Gla holders....this will bounce big time on positive news, Trading statement/ Update now due, and disclosure of their global biopharma on successful technology trials in the coming months will be a game changer and Msys's share price will be many multiples of today's current bargain low...Watch this Space!!! :-)
moneymunch
19/1/2018
11:28
Chart-buster - support at 2.5p
2prsimo
19/1/2018
11:26
I have funds waiting but looks like little support on today's dip so could see low 2's Maybe I'm being a little greedy ;)
stephen2010
19/1/2018
11:23
Stephen, You must be tempted???
k1ngkonggb
19/1/2018
11:21
Spiked again lol. When will moneymoron ever learn
stephen2010
19/1/2018
11:21
How your average looking moneymoron ;). 2.5p I did say
stephen2010
19/1/2018
11:18
4m in cash on Bal sheet
nw99
19/1/2018
11:17
Incredibly cheap today under £6m market cap with over £3m in cash. The likes of lion are at 5 times our market cap. Someone should tell the punters there to wake up and move over to this.
jungmana
19/1/2018
11:03
Can buy fine. Tempted.
babbler
19/1/2018
10:50
NT to buy . Big orders being filled in the background imo :-)
jungmana
19/1/2018
10:46
Stephen, Getting closer to your target...don't change your mind now!!!
k1ngkonggb
Chat Pages: 53  52  51  50  49  48  47  46  45  44  43  42  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180123 10:12:06